..... in Australien und darf produzieren und vertreiben und hat in Australien das Monopol und wenn ich das hier so lese sollte es mehrere Tage nach oben laufen und die Australier werden es diese Nacht erst richtig checken was für eine Perle sie hier haben - alles nur meine Meinung keine Kauf oder Verkauf Entscheidung -
4 January 2018 FEDERAL GOVERNMENT TO ALLOW CANNABIS EXPORT AusCann Group Holdings Ltd (ASX:AC8) (?AusCann? or ?the Company?) welcomes the Federal Government announcement today from Health Minister Greg Hunt to allow manufactured cannabinoid medicines to be exported from Australia. This puts AusCann in a very valuable position as the only company with the full set of the necessary licences to grow and manufacture cannabinoid medicines in Australia. AusCann has the only established TGA licensed manufacturing facility through their partnership with Tasmanian Alkaloids. AusCann, Managing Director Elaine Darby said ?This is a win for the Australian Cannabis industry and Australian patients as it allows us to produce cost effective products at scale. We are perfectly positioned to create high value export products from AusCann and have the international relationships in place including Canopy, the largest producer in North America and also our largest shareholder in AusCann.? ?AusCann remains committed to Australian patients as a priority and has developed the medical outreach program that is already educating doctors and health practitioners in Australia on the use of cannabinoid medicines.? -ENDSFor more information please contact AusCann Elaine Darby Managing Director email@example.com +61 458 372 511 For Media Enquiries Caroline Zielinski Media & Capital Partners Caroline.firstname.lastname@example.org +61 400 172 145 ABOUT AUSCANN GROUP AusCann is an Australian based company that was incorporated in September 2014 with the aim of producing and providing high quality, economical and clinically validated cannabinoid medicines to patients. It is bringing together leading expertise and operations across all aspects of the medical cannabis value chain, beginning with cultivation and production, through to manufacture and distribution of final dose form medications and has built a strong team of experts and partners with international connections. Partners include TSX listed Canopy Growth Corporation the largest producer of medicinal cannabis globally, DayaCann, the only licensed medicinal cannabis grower in Chile and Tasmanian Alkaloids, producer of approximately 40% of the worlds opiate supply.